Product information and disease descriptionPlace of product in therapyDisease description
Pathophysiology
5 evidence topics · 4 sources
Bradykinin generation: activation of prekallikrein to plasma kallikrein
“In HAE-C1-INH, bradykinin is the primary mediator of swelling.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“This molecule arises from cleavage of high-molecular-weight kininogen by plasma kallikrein, which is activated from prekallikrein by factor XII.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“The resulting bradykinin nonapeptide increases vascular permeability and induces swelling (angioedema) through a specific receptor, B2” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Role of C1 inhibitor in regulating the kallikrein-kinin system
“C1-INH is a serine protease inhibitor protein synthesized in hepatocytes that is crucial in regulating the plasma kallikrein–kinin system (KKS) and preventing excessive bradykinin production.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“HAE-C1-INH is caused by mutations in SERPING1, which encodes C1-INH, leading to reduced levels or impaired activity of C1-INH.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“This deficiency in turn leads to uncontrolled activation of the KKS and excessive bradykinin production, with bradykinin acting as the key mediator of the condition.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote